Cadrenal Therapeutics, Inc. (CVKD) › Capital ExpendituresCadrenal Therapeutics, Inc. (CVKD) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2023: $3.3K2024: $6.5K2025: $5.1K$5.1K2023Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$5.1K-21.9%2024$6.5K+100.9%2023$3.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share